For caregivers with cardiovascular conditions, poor sleep and emotional distress are linked to greater strain
Peer-Reviewed Publication
Updates every hour. Last Updated: 19-Oct-2026 12:16 ET (19-Oct-2026 16:16 GMT/UTC)
A new MUSC study published in JAMA Pediatrics reveals a striking reversal in youth vaping trends: Girls are now vaping at higher rates than boys. Among teens ages 15 to 17, regular vaping among girls rose from 4.9% in 2021 to 7.8% in 2024, compared with 4.6% of boys. Although cigarette smoking among adolescents has fallen to historic lows, researchers warn that nicotine addiction remains a serious concern. “We have to sound the alarm bells for girls,” said Benjamin Toll, Ph.D., of MUSC Hollings Cancer Center. “But we also need to make sure that we’re addressing the boys, too.” The findings highlight the need for targeted prevention and treatment efforts to address changing patterns of youth nicotine use.
People with ADHD face higher mortality rates, but taking medication may mitigate this risk, finds a study led by UCL and University of Liverpool researchers.
An international clinical trial found that adults with major depression can successfully complete a six-week course of home-based brain stimulation combined with a video game after up to five instructional clinic visits. The study, conducted through clinical centers in Jerusalem, Riga, and Munich, achieved its primary objective by demonstrating the feasibility of remote treatment. However, the experimental combination of active transcranial direct current stimulation (tDCS) and computerized cognitive training did not lead to greater improvement than a “double-sham” control condition combining sham brain stimulation with a control game. Both groups showed a marked reduction in depressive symptoms, raising important questions about which elements of the treatment experience may contribute to improvement.
Researchers from the University of Osaka uncovered the first steps of disease development in ANCA-associated autoimmune glomerulonephritis. Injured kidney cells send signals to attract immune cells, including neutrophils, and induce inflammation. The researchers tested the effects of modified antibodies on halting disease progression in a mouse model, showing that the modified antibodies successfully reduced kidney injury. The findings offer hope for a potential treatment aimed at stopping the disease at its earliest stage.